FDA to consider over-the-counter birth control pill from French drugmaker

birth control pills.
(Image credit: JIM WATSON/AFP via Getty Images)

A Paris-based pharmaceutical company on Monday asked the U.S. Food and Drug Administration to authorize its birth control pill for over-the-counter purchase, multiple outlets have reported. It's the first such request the FDA has ever received.

The company, HRA Pharma, said the timing of its application is unrelated to the recent Supreme Court decision to overturn landmark abortion rights case Roe v. Wade (1973). The pill in question — known as Opill — has not been sold in the U.S. for over a decade, per The Washington Post. The company's request, meanwhile, "sets up a high-stakes decision for health regulators amid legal and political battles over women's reproductive health," The Associated Press contends.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Brigid Kennedy

Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.